- Filed
- Aug 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 4, 2025 | 135.06M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 136.5M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 138.14M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 136.98M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 136.84M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $215.45M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $84.79M |
| Capex | Q2 2025 · Jun 30, 2025 | $82.67M |
| Capex | Q2 2025 · Jun 30, 2024 | $56.37M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $255.17M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $106.65M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $4.3B |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $4.09B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $4.18B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $3.98B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $3.92B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $4B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $424.66M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $855.91M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $665.41M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $1.07B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $1.73B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $2.18B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $4.96B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $5.25B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $1.49 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $2.01 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.23 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.18 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $1.50 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $2.05 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.23 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.18 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $303.62M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $546.42M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $239.45M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $488.13M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $39.95M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $73.02M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $37.7M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $94.97M |
| Net Income | Q2 2025 · Jun 30, 2025 | $202.85M |
| Net Income | Q2 2025 · Jun 30, 2025 | $278.31M |
| Net Income | Q2 2025 · Jun 30, 2024 | $31.76M |
| Net Income | Q2 2025 · Jun 30, 2024 | $24.64M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $76.11M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $173.11M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $49.62M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $57.62M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $248.77M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $444.16M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $260.04M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $501.53M |
| Revenue | Q2 2025 · Jun 30, 2025 | $745.34M |
| Revenue | Q2 2025 · Jun 30, 2025 | $1.34B |
| Revenue | Q2 2025 · Jun 30, 2024 | $629.69M |
| Revenue | Q2 2025 · Jun 30, 2024 | $1.24B |